RE:Reverse Split !!!Fully agree with you , but that's what we sign up for when we invest with a company with no cash flows in the past nor in the near future(Serology revenue will be peanuts) may be the risk will pay off in future. Acumen after their ipo is down around 30% .. but their market cap is much higher. May be we will get there after all this nasdaq stuff, definitely not just with retail Investors